The consistency of results across racial groups suggests that, within the controlled setting of clinical trials, ...

Patients with ECOG performance status of 1 reported worse global health status, quality of life, and physical functioning than those with a status of 0. The RATIONALE-305 trial showed Tevimbra plus ...

Bridging therapy was administered to 90% of apheresed patients, with chemotherapy ± radiotherapy used in 53% and targeted therapy alone in 23%, reflecting heterogeneous, risk- and access-driven ...

In the companion to this article, Dr Ruiz et al 5 conducted an analysis of two prospective studies using wearable accelerometer-based evaluations to define patients' fitness through a new score known ...